Eli Lilly CEO discusses its coronavirus antibody drug and the latest on its breast cancer treatment

Eli Lilly CEO and Chairman Dave Ricks joined CNBC's Jim Cramer on Monday, discussing the results of its study on its breast cancer treatment Verzenio. Ricks also touted the "proof-of-concept" data for its Covid-19 antibody treatment.